Advisory Services Network’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3,100
Closed -$5.24K – 4173
2026
Q1
$5.24K Buy
+3,100
New +$6.38K ﹤0.01% 3830
2025
Q4
– Sell
-300
Closed -$873 – 3805
2025
Q3
$873 Buy
+300
New +$690 ﹤0.01% 3959
2024
Q4
– Sell
-11,800
Closed -$146K – 1699
2024
Q3
$146K Hold
11,800
– – ﹤0.01% 1433
2024
Q2
$146K Sell
11,800
-21,400
-64% -$451K ﹤0.01% 1433
2024
Q1
$674K Buy
33,200
+19,290
+139% +$444K 0.01% 833
2023
Q4
$313K Sell
13,910
-5,590
-29% -$118K 0.01% 1073
2023
Q3
$324K Sell
19,500
-400
-2% -$7.93K 0.01% 1109
2023
Q2
$488K Sell
19,900
-554
-3% -$13.3K 0.01% 924
2023
Q1
$493K Buy
20,454
+9,600
+88% +$266K 0.01% 914
2022
Q4
$321K Buy
10,854
+5,800
+115% +$208K 0.01% 1051
2022
Q3
$211K Sell
5,054
-1,125
-18% -$30.4K 0.01% 1177
2022
Q2
$174K Buy
6,179
+205
+3% +$5.18K 0.01% 1264
2022
Q1
$222K Sell
5,974
-10,201
-63% -$432K 0.01% 1294
2021
Q4
$707K Buy
16,175
+14,762
+1,045% +$774K 0.02% 745
2021
Q3
$88K Buy
+1,413
New +$118K ﹤0.01% 1346
2020
Q4
– Sell
-660
Closed -$8K – 3652
2020
Q3
$8K Buy
+660
New +$2.98K ﹤0.01% 2575

Other funds holding FLNA

Advisory Services Network's FLNA Position: Q2 2026 in Review

Advisory Services Network sold out of Filana Therapeutics (FLNA) in Q2 2026, closing a stake of 3,100 shares — an estimated $5.24K sold.

Advisory Services Network first reported a position in FLNA in Q3 2020 and held it in 16 quarters. The position peaked at $707K in Q4 2021. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Advisory Services Network reported no remaining Filana Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 3,100 Filana Therapeutics shares in Q2 2026, an estimated $5.24K.
  • Advisory Services Network first reported a position in Filana Therapeutics in Q3 2020 and held it in 16 quarters.
  • Advisory Services Network's Filana Therapeutics position peaked at $707K in Q4 2021.
  • 85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.